Crispr Therapeutics shares tumble after significant earnings miss
Thaddeus Gerard Weed, the Vice President and Chief Financial Officer of Cogent Communications Holdings, Inc. (NASDAQ:CCOI), recently sold a portion of his holdings in the company. According to the latest SEC filing, Weed sold 4,900 shares of common stock on June 9, 2025, at an average price of $48.04 per share. This transaction resulted in a total sale value of $235,396. Following the sale, Weed retains ownership of 98,000 shares in the company.The sale comes as Cogent’s stock has declined over 35% in the past six months, though the company maintains an attractive 8.44% dividend yield. InvestingPro analysis indicates the company currently trades above its Fair Value, with a weak overall financial health score. According to InvestingPro, there are 12 additional key insights available about Cogent’s financial position and market performance, helping investors make more informed decisions.
In other recent news, Cogent Communications Holdings, Inc. announced its first-quarter 2025 earnings, which showed a slight miss on both earnings per share (EPS) and revenue compared to forecasts. The company’s EPS was reported at -1.09 USD, against a forecast of -1.05 USD, while revenue reached 247 million USD, falling short of the projected 251.36 million USD. Additionally, Cogent has launched a $600 million senior secured notes offering, with plans to use part of the proceeds to redeem existing notes and for general corporate purposes. Analyst firms have reacted to these developments; Citi’s Michael Rollins reduced the price target for Cogent’s stock from $82 to $67, maintaining a Buy rating, while JPMorgan’s Philip Cusick lowered the target to $62, keeping a Neutral rating. Despite these adjustments, analysts see potential in Cogent’s capacity to improve financial performance and monetize non-core assets. Moreover, Cogent’s stockholders approved amendments to its incentive award plan and bylaws during the recent Annual Meeting. These updates include increasing the number of shares available for issuance and adjusting the size of the Board.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.